Hong-yan Tong

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Idiopathic Multicentric Castleman Disease-TAFRO: A Potentially Curable Disease?

Idiopathic Multicentric Castleman Disease-TAFRO: A Potentially Curable Disease?

Journal: American journal of hematology
Published: September 16, 2025

A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia.

A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 14, 2021

Decitabine combined with low dose idarubicin and cytarabine (D-IA) followed by allo-HSCT improves acute myeloid leukemia and higher-risk myelodysplastic syndrome patient outcomes: results from a retrospective study.

Decitabine combined with low dose idarubicin and cytarabine (D-IA) followed by allo-HSCT improves acute myeloid leukemia and higher-risk myelodysplastic syndrome patient outcomes: results from a retrospective study.

Journal: Leukemia & lymphoma
Published: March 08, 2021

Coagulation profile in newly diagnosed T-cell acute lymphoblastic leukemia.

Coagulation profile in newly diagnosed T-cell acute lymphoblastic leukemia.

Journal: Thrombosis research
Published: January 03, 2021

CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.

CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.

Journal: American journal of hematology
Published: August 25, 2020

A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemia.

A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemia.

Journal: American journal of cancer research
Published: August 16, 2020

Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.

Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.

Journal: Frontiers in oncology
Published: April 21, 2020

An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.

An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: March 15, 2020

Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study.

Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study.

Journal: Leukemia & lymphoma
Published: February 17, 2018

Therapeutic Efficacy of VICP+L-ASP/TKI on Adult Patients with B-ALL

Therapeutic Efficacy of VICP+L-ASP/TKI on Adult Patients with B-ALL

Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 28, 2016

Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.

Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.

Journal: Leukemia & lymphoma
Published: September 16, 2015

Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.

Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.

Journal: PloS one
Published: June 12, 2015
Showing 1-12 of 19

Last Updated: 09/26/2026